With the approval of Wegovy HD, Novo Nordisk joins Johnson & Johnson, Boehringer Ingelheim and USAntibiotics as beneficiaries ...
What if treating obesity could be as easy as popping an effective pill? That's a notion that has long fueled hope for many of the more than 40% of Americans who are considered obese — and fueled ...
A novel scoring system can effectively stratify patients with autoimmune inflammatory rheumatic diseases into high- and low-risk groups for serious infections after high-dose glucocorticoid therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results